BIVDA Press Releases

22Sep

BIVDA Attends UN Meeting on Antimicrobial Resistance

Doris-Ann Williams MBE, Chief Executive of the British In Vitro Diagnostics Association (BIVDA), represented the IVD industry at the United Nations General Assembly meeting on antimicrobial resistance (AMR) on Wednesday (22 September 2016).

Bringing together Member States, non-governmental organizations, civil society, private sector and academic institutions from across the globe, the aim of the meeting was to increase awareness and understanding of AMR and establish a collaborative commitment to tackling the issue.

It was announced that a Declaration agreeing to combat antimicrobial resistance had been signed by 193 countries at the United Nations General Assembly.

Commenting on the meeting and Declaration, BIVDA’s Chief Executive Doris-Ann Williams MBE said:

“I was delighted to represent the IVD industry at the United Nations General Assembly meeting on AMR yesterday. BIVDA has been an active supporter of the UK’s efforts to put AMR at the forefront of the global health agenda, therefore, we welcome the announcement that a landmark declaration to tackle AMR has been signed by 193 countries at the United Nations General Assembly.

“IVDs have and will continue to play a critical role in tackling the AMR challenge by helping to reduce cases of unnecessary antibiotic prescribing and enabling a more targeted use of therapy against infection where identified by a test. Consequently, we urge all healthcare professionals in the UK to make use of the quick, accurate and effective IVDs available to them now”.

Notes to Editor:

BIVDA is the industry association for manufacturers and suppliers of IVD tests. We represent over 100 members, ranging from British start-up companies to UK subsidiaries of multinational corporations. BIVDA member companies employ more than 8,000 people in the UK, with a total industry turnover of approximately £900 million.

For further information, please contact External Affairs Manager Emma Thomas at emma@bivda.co.uk or 0845 6188224.  

Related

BIVDA Response to the Life Sciences Sector Deal

Commenting on the publication of the Life Sciences Sector Deal (6th December 2017), BIVDA’s Chief E...

Read More >

BIVDA comment on the Health and Social Care Committee’s report into Antimicrobial resistance

Today the Health and Social Care Committee has published its report on Antimicrobial resistance.

Read More >

BIVDA response to the Secretary of State for Health and Social Care's vision for prevention

Today the Secretary of State for Health and Social Care, Matt Hancock MP, has announced his vision f...

Read More >

BIVDA, ABPI and CRUK release briefing on new arrangements for commissioning and funding of six molecular diagnostic tests for cancer

BIVDA, ABPI and CRUK have released a stakeholder briefing to clarify the new arrangements for commis...

Read More >

BIVDA response to Parliament’s vote on the Brexit deal

Doris-Ann Williams, Chief Executive of BIVDA, comments on Parliament’s vote on the Brexit deal

Read More >

BIVDA publishes report looking at the point of care testing environment in the UK

BIVDA has today published a report looking at the findings of its survey of point of care coordinato...

Read More >